Overall survival with adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with high-risk HR+/HER2– early breast cancer: Six-year follow-up of the NATALEE trial
Publication date: Available online 23 October 2026 Source: Annals of Oncology Author(s): D.J. Slamon, G.N. Hortobagyi, D. Stroyakovskiy, D.A. Yardley, C.-S. Huang, J. Crown, A. Bardia, S. Chia, S.-A. Im, M. Martin, S. Loi, B. Xu, S.A. Hurvitz, C.H. Barrios, A. Cuesta Fernández, M. Untch, F. Visco, A.L. Perez, M. Miller, S. Majumdar
Overall survival with adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with high-risk HR+/HER2– early breast cancer: Six-year follow-up of the NATALEE trial. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426086400?dgcid=rss_sd_all
Overall survival with adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with high-risk HR+/HER2– early breast cancer: Six-year follow-up of the NATALEE trial. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426086400?dgcid=rss_sd_all
“Overall survival with adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with high-risk HR+/HER2– early breast cancer: Six-year follow-up of the NATALEE trial.” Annals of Oncology.
@article{article36283,
title = {Overall survival with adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with high-risk HR+/HER2– early breast cancer: Six-year follow-up of the NATALEE trial},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426086400?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...